Tampa MD's DEA License Revoked for Sharing Prescription Privileges Illegally
Published Date: 4/16/2025
Notice
Summary
Dr. Victor Augusto Silva from Tampa had his DEA registration suspended and then revoked because he let someone else illegally use his license to prescribe drugs. Since he didn’t respond in time to defend himself, the government decided he’s a risk to public safety and took away his registration for good. This means he can’t legally prescribe controlled substances anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked — No Prescribing
The Drug Enforcement Administration revoked Victor Augusto Silva, M.D.'s DEA Certificate of Registration No. FS3590266 and denied any other pending registration application in Florida. The Order takes effect May 16, 2025, and means Dr. Silva may not lawfully prescribe controlled substances after that date.
Entrusting DEA Registration Is Strict Liability
The Agency found that allowing an unauthorized person to use a DEA registration to prescribe controlled substances violates federal law (21 CFR 1306.04(a)) and Florida law (Fla. Stat. section 458.331(f)), and that a registrant is strictly liable for misuse. The record states Respondent allowed an unlicensed individual (B.L.) to access and use his registration in 2023, including as recently as December 2023.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-17594, Atlantic Treatment Center, LLC; Decision and Order
2026-17589, Leila Kump, M.D.; Decision and Order
2026-17592, Thomas Earley, D.D.S.; Decision and Order
2026-17531, Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
The Drug Enforcement Administration (DEA) issues this temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4- yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4- chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro desmethylchlorphine or SR-17018); 3-(3- (1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H- benzo[d]imidazol-1-yl)propanenitrile (commonly known as N-propionitrile chlorphine or cychlorphine); and 8-(1-(4-chlorophenyl)ethyl)-1-phenyl- 1,3,8-triazaspiro[4.5]decan-4-one (commonly known as spirochlorphine or R-6890), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, to schedule I under the Controlled Substances Act. DEA bases this action on a finding that placing 5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N- propionitrile chlorphine, and spirochlorphine in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances.
Previous / Next Documents
Previous: 2025-06452, Ajumobi Agu, M.D.; Decision and Order
Dr. Ajumobi Agu from Las Vegas lost his DEA license because he kept giving out controlled medicines after his state licenses were suspended. Since he didn’t ask for a hearing, the DEA decided to revoke his registration to keep the public safe. This means he can’t legally handle controlled substances anymore, effective immediately, protecting patients and the community.
Next: 2025-06455, Presidential Declaration Amendment of a Major Disaster for Public Assistance Only for the Commonwealth of Kentucky
Kentucky’s disaster declaration just got an upgrade! This update means more help is coming for public projects damaged by storms, floods, and mudslides starting March 4, 2025. Local governments and public agencies can now access extra support to fix things faster and stronger.